ArticlePharmaceuticals (Basel, Switzerland)2025
Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models.
Quang Trung Ngo, Jorge Luis Espinoza, Hongyang Li, Masafumi Inokuchi, Yosuke Nakanishi, Eriko Morishita, Takamasa Katagiri, Akihiro Kawahara, Tomokazu Yoshizaki, Akiyoshi Takami and 1 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Quang Trung NgoKampo Clinical Center, Hiroshima University Hospital, 1 Chome-2-3 Kasumi, Minami Ward, Hiroshima 734-8551, Hiroshima, Japan.ORCID 0000-0002-8386-137X Jorge Luis EspinozaFaculty of Health Sciences, Kanazawa University, Kanazawa 920-0942, Ishikawa, Japan.ORCID 0000-0002-1794-6666 Hongyang LiKampo Clinical Center, Hiroshima University Hospital, 1 Chome-2-3 Kasumi, Minami Ward, Hiroshima 734-8551, Hiroshima, Japan.ORCID 0009-0005-4778-7810 Masafumi InokuchiDepartment of Breast Oncology, Kanazawa Medical University, Kahoku-gun, Kanazawa 920-0293, Ishikawa, Japan.ORCID 0000-0001-8886-9517 Yosuke NakanishiDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan.
Eriko MorishitaDepartment of Clinical Laboratory Science, Graduate School of Medical Science, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-0942, Ishikawa, Japan.ORCID 0000-0001-9116-3363 Takamasa KatagiriDepartment of Clinical Laboratory Science, Graduate School of Medical Science, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-0942, Ishikawa, Japan.ORCID 0000-0002-9568-8682 Akihiro KawaharaKampo Clinical Center, Hiroshima University Hospital, 1 Chome-2-3 Kasumi, Minami Ward, Hiroshima 734-8551, Hiroshima, Japan.
Tomokazu YoshizakiDivision of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan.
Akiyoshi TakamiDepartment of Internal Medicine, Division of Hematology, School of Medicine, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.ORCID 0000-0002-1822-9976 Keiko Ogawa-OchiaiKampo Clinical Center, Hiroshima University Hospital, 1 Chome-2-3 Kasumi, Minami Ward, Hiroshima 734-8551, Hiroshima, Japan.ORCID 0000-0002-3277-0646 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
apoptosiscancerimmune modulationjuzentaihotoKampo medicinenatural productstraditional medicine
Identifiers
PMID41304903
PMCPMC12655088
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390